Directory · IT
Biotechnology in Italy
A register of firms and the professionals working at them in the Biotechnology sector based in Italy. Browse the public index, then filter or export on Kipplo.
Companies
118 on file
Centro Sperimentale Del Latte S.R.L
Centro Sperimentale del Latte (CSL) was the first company in Italy to study Lactic Acid Bacteria (LAB) for human health. It was founded by Dr Leo Vesely in 1948 with a mission to improve maternal health and children’s nutrition. Since 2013 CSL has been part of Sacco System, the international biotech hub, for food, nutraceutical, and pharmaceutical industries; our expertise helps solve consumer needs in more than 110 countries around the world, leveraging our unique proprietary strains and customised blends. After more than 70 years, CSL continues to focus on probiotic manufacturing, research and development in the nutraceutical and pharmaceutical fields. Our know-how is not limited to LAB, but with our two facilities, drug-GMP certified we can support companies in the development, process validation, and commercial production of probiotics, postbiotics, Next-Generation bacteria (obligate aerobes and anaerobes strains) and biotherapeutics (BPs)
51 to 200 staff
Steroglass S.R.L
La nostra missione Steroglass è una società che ha lo scopo di sviluppare, produrre e commercializzare prodotti e apparecchiature innovativi, di alta qualità, per l'uso scientifico destinate ai settori della chimica industriale, alimentare, ambientale, della diagnostica e delle biotecnologie; inoltre, produce e commercializza con il marchio Blueside una linea di prodotti di design con materiali legati alla tradizione Steroglass. Steroglass vuole, in particolare, essere azienda di riferimento nel settore enologico-alimentare sia in termini di competenza e assistenza tecnico applicativa che per l'ampia gamma di prodotti nel settore del laboratorio. I nostri valori Nella gestione delle proprie attività, Steroglass si ispira ai seguenti valori- attenersi alle più rigorose norme di etica professionale nelle proprie attività- essere partner leale in ogni azienda ed in ogni centro di ricerca nell'ambito dei quali si trovi- tutelare la sicurezza e la salute nei luoghi di lavoro e ritenere fondamentale il rispetto dei diritti dei lavoratori nell'espletamento della propria attività- la gestione dei rapporti di lavoro è orientata a garantire pari opportunità ed a favorire la crescita professionale di ciascuno.
51 to 200 staff
Tecniplast
Tecniplast, world leading company in the Lab Animal Industry since 1949, designs, manufactures and distributes equipment for vivarium. We offer the most complete product portfolio ranging from IVCs, Biocontainment/Bioexclusion, Analysis, Aquatic equipment, Laminar Flow, Cage and Rack washers, Bedding Handling and Disposal systems, Decontamination and Automation, as well as Accessories. Tecniplast has recently introduced the first Digital Ventilated Cage (DVC®), enhancing the threshold in animal welfare, in users ergonomics and in management of Animal Lab Facilities. Our constant investments in technologies, automation, production capabilities, stock availability, certifications for quality and environmental sustainability are a clear evidence of our commitment to provide the most complete and reliable range of products. Tecniplast Group is present in Italy, UK, Germany, France, Switzerland, USA, Canada, China, Australia, Japan. Our global presence is based on a network of more than 70 international representatives. OUR POLICY On this page we will publish updates regarding Tecniplast products and services, researches, interviews and any material useful for sharing experiences and knowledge. To develop the dialogue in a meaningful way we provide some simple rules: 1. Comments are welcome as long as they are relevant to the topics, bring added value to the discussion and comply with Tecniplast mission of delivering solutions that enhance scientific research outcomes improving animal model welfare. Comments mentioning third party companies or containing links to external sites are permitted as long as there are no direct references to Tecniplast competitors 3. The language and tones must be appropriate. Comments deemed offensive or detrimental to the image or good repute of third parties (spam, comparative advertising, racists.) won't be accepted. Any comment or content that we believe has violated these simple rules will be deleted at our sole discretion.
501 to 1000 staff
Newron Pharmaceuticals Spa
Newron (SIX: NWRN, XETRA: NP5) is a biopharmaceutical company focused on the development of innovative therapies for patients with diseases of the central and peripheral nervous system. Headquartered in Bresso near Milan, Italy, the Company has a strong track record of advancing neuroscience-based treatments from discovery to market. Newron’s lead compound, evenamide, is a first-in-class glutamate modulator and has the potential to be the first add-on therapy for treatment-resistant schizophrenia (TRS) and for poorly responding patients with schizophrenia. Evenamide is currently developed in the global pivotal ENIGMA-TRS Phase development program. Clinical trial results to date demonstrate the benefits of this drug candidate in the TRS as well as poorly responding patient population, with significant improvements across key efficacy measures increasing over time, as well as a favorable safety profile, which is uncommon for available antipsychotic medications. Newron has signed development and commercialization agreements for evenamide with EA Pharma (a subsidiary of Eisai) for Japan and other Asian territories, as well as Myung In Pharm for South Korea. Newron’s first marketed product, Xadago®/safinamide has received marketing authorization for the treatment of Parkinson’s disease in the European Union, Switzerland, the UK, the USA, Australia, Canada, Latin America, Israel, the United Arab Emirates, Japan and South Korea. The product is commercialized by Newron’s partner Zambon, with Supernus Pharmaceuticals holding marketing rights in the U.S, and Meiji Seika responsible for development and commercialization in Japan and other key Asian territories.
11 to 50 staff
Resnova Srl
La Resnova è una Società a capitale interamente italiano che opera da 27 anni nel campo della distribuzione sul territorio nazionale offrendo soluzioni innovative, in termini di prodotti e servizi, destinate alla Ricerca Biomedica, Biotecnologica, Farmaceutica ed Agro-alimentare, oltre che a quello della Diagnostica avanzata, nei settori della Sanità Pubblica, dell’Università e degli Enti pubblici e privati.
11 to 50 staff
Gelesis
Gelesis is an innovative biotech company working to improve people’s lives so that patients, healthcare professionals and societies are empowered in the face of metabolic disease.
51 to 200 staff
Igrox Srl
Igrox® designs and produces LED technology for cultivation in controlled environment. Our solutions contribute to elevate yield and enhance quality of crops while ensuring sustainability through our cutting edge technology. We are at the forefront of the study and application of specific spectra to control morphology, vegetative or generative growth and all the biological and technological aspects that our clients consider useful for their success in hi-tech agriculture. We focus our activity on microalgae cultivation too, reshaping the way in which super food, active pharmaceuticals and new smart biomaterials are produced.
1 to 10 staff
Wikenfarma Srl
Wikenfarma è un'azienda specializzata e focalizzata in dermatologia ed in particolar modo in tricologia, in quanto i suoi prodotti sono specifici per patologia, età e sesso. A differenza del 90% di tutte le altre realtà che formulano prodotti generalisti, le formulazioni Wikenfarma catturano l'attenzione dei medici in quanto sono le uniche che mettono in pratica il concetto di terapia sartoriale per curare i pazienti in base alle loro reali esigenze.
1001 to 5000 staff
Arterra Bioscience S.P.A
Arterra Bioscience is a biotech company listed on the “Euronext Growth Milan” market of Borsa Italiana since 2019, founded in Naples by M. Gabriella Colucci in 2004 with the aim of developing technologies and innovative solutions that find application in various industrial sectors. Arterra is a company strongly linked to the Campania region from which it derives the natural raw materials underlying many of its actives, as well as being able to take advantage of the ideas and enthusiasm of its young researchers.
11 to 50 staff
Bio-Circle Italia
Bio-Circle è un'azienda specializzata nell’ottimizzare i processi di sgrassaggio e pulizia pezzi soprattutto in termini di sicurezza ed efficienza.
11 to 50 staff
Ever Srl
Dal 1973 lavoriamo fianco a fianco di enologi, agronomi e cantine con lo stesso obiettivo: realizzare un vino in grado di soddisfare le richieste dei consumatori, proponendo soluzioni di valore e sostenibili per l’enologia. Dalla nostra sede di Pramaggiore, in provincia di Venezia, abbiamo costruito una rete capillare di filiali e distributori per portare il nostro know-how in tutto il mondo.
11 to 50 staff
Galileo Research Srl
Galileo Research origins lie in 1972 as the Research Centre of Istituto Gentili, an Italian pharmaceutical company founded in 1917. At the beginning of the ‘80s, scientists at the Gentili Research Centre discovered and developed new molecules in the class of bisphosphonates and in the field of bone diseases, in particular clodronate and alendronate. The Research Centre continued to work in the field of bone and joint metabolism and also expanded its knowledge and activities to the areas of oncology and CNS. Galileo Research was established in July 2011.
11 to 50 staff
B-Plas Sbrl
B-Plas Sbrl - benefit company - designs and builds fully automated plants that transform wastewater sludge into PHA, a bio-based and biodegradable bioplastic, with a lower environmental impact than available technological alternatives. B-Plas adopts the principles of "Green Growth" in its circular technology model, embracing a path of environmentally and socially sustainable economic growth. Through an innovative process, B-Plas applies a concrete and effective solution to the "sludge problem" with the aim of: • Propose a sustainable management of wastewater sludge, creating economic, environmental and social benefits; • Offering an alternative to traditional methods in a perspective of circular economy. B-Plas treats sludge: • agrro-food • from civil and industrial purification • from the paper manufacturing industry • from biological treatment of industrial waste water B-Plas improves the chemical and physical characteristics of the dewatered sludge at the outlet, without altering its legal classification. The biodegradable and compostable PHA produced is then purchased from at an agreed price. Subsequently, the PHA is stored and marketed for the production of environmentally sustainable materials and products for applications in 3D printing, agriculture, giftware, green building, packaging & catering.
1 to 10 staff
Bba Ecotech
Biotechnology meets human relationships. Each microorganism we propose simplifies the complexity of your daily challenges, each of our services meets your every need. We transfer our technical and relational expertise to every solution, always focusing on quality safety and sustainable innovation.
11 to 50 staff
Herbolea Biotech S.P.A
Herbolea is a biotech company envisioning the use of innovative, green technologies to obtain safe, high-quality and low-cost natural products. Herbolea’s patented Bio-refining Platform generates unique products from highly therapeutic potential botanicals in a safe, environmentally friendly, and cost-competitive way. The company has signed licensing agreements with pharmaceutical companies in US, Canada, Colombia, Germany, Portugal, Italy, Zimbabwe, Thailand and Morocco. The company has assembled a team of highly seasoned executives with a proven track record in building successful companies.
11 to 50 staff
Prometheus Srl
Prometheus è una start-up biotech fondata nel 2017 e attiva nello sviluppo di dispositivi medicali per la medicina rigenerativa, sia in ambito umano che veterinario. Il primo prodotto, Ematik, è un patch personalizzato per la cura delle ferite cutanee, pensato per accelerare la guarigione e migliorare la qualità rigenerativa dei tessuti. Con il sistema automatizzato Ematik Lab, Prometheus ha reso il trattamento riproducibile, sicuro e standardizzato, offrendo risultati affidabili sia per i professionisti medici sia per i veterinari. Nel 2025, con l’acquisizione di Alnitec, leader nel campo dell’ozonoterapia, il gruppo ha ampliato le sue competenze terapeutiche, diventando un riferimento europeo nella tecnologia rigenerativa.#Innovation #Biotech #Startup #Healthcare #MedTech #Vet #MadeInItaly
1 to 10 staff
Rigenerand Srl
Acquired by Evotec SE in July 2022, Rigenerand is now operating as Evotec (Moderna) Srl. Originating as a start-up from the University of Modena and Reggio Emilia developing and producing innovative products for pre-clinical and clinical applications of cell-based technologies for regenerative medicine and oncology, the cell technology company aims to fill therapeutic gaps for the many still incurable diseases by manufacturing smart treatments based on gene-modified cells with a specific focus on cancer With its team of leading cell therapy experts, Evotec (Moderna) adds a high-quality cGMP manufacturing site to the EVOcells platform increasing capacity, critical expertise, and capabilities to the scale-up of complex cell-based therapies.
11 to 50 staff
Biouniversa S.R.L
BIOUNIVERSA s.r.l. is an academic Spin-Off of the University of Salerno founded in 2009. BIOUNIVERSA is focused on discovery and development of Diagnostic and Therapeutic Products based on the BAG3 protein. Specific kits based on BAG3 antibodies, owned by BIOUNIVERSA, have been validated or are in the validation phase as biomarkers for pancreatic cancer and cardiovascular diseases.
11 to 50 staff
Celltrion Healthcare Italia
Celltrion Healthcare è specializzata nella ricerca e nello sviluppo di farmaci biosimilari e di terapie innovative, con l'obiettivo di offrire cure sostenibili e alla portata di tutti. Favorire l’accesso dei pazienti a terapie avanzate e di alta qualità è alla base del nostro impegno, che portiamo avanti dal Ad oggi abbiamo reso disponibili in più di 100 paesi medicinali biosimilari per la cura di patologie autoimmuni come l’artrite reumatoide, la colite ulcerosa, il morbo di Chron e la psoriasi. Di recente, Celltrion Healthcare si è impegnata in prima linea nella lotta al Covid-19 mettendo a punto test diagnostici rapidi per la rilevazione del virus, disponibili in Italia da novembre 2020, e sta sviluppando un nuovo trattamento per la cura del Coronavirus. Con sede in Corea, Celltrion Healthcare vanta uno dei più grandi e moderni impianti di coltura cellulare al mondo, con una capacità di produzione totale di litri. Il gruppo Celltrion svolge attività di marketing, vendita e distribuzione di medicinali biologici attraverso una vasta rete globale che copre più di 120 paesi diversi. Ultimamente ha aperto anche una filiale in Italia, con sede operativa a Milano.
11 to 50 staff
Diatech Lab Line
Prima ricercatori, poi rivenditori. Diatech Lab Line non è semplicemente il nome di una nuova azienda che s’inserisce in una schiera di distributori di prodotti per la ricerca biomedica, è molto di più. I reagenti e gli strumenti presentati in questo catalogo sono correntemente utilizzati nei nostri laboratori di ricerca e sviluppo dove, da anni, si mettono a punto kit di diagnostica molecolare dedicati principalmente alla farmacogenetica oncologica. Diatech Lab Line seleziona nel vasto mercato internazionale i prodotti migliori e innovativi per destinarli alla ricerca italiana. La nostra missione ci ha finora fatto guadagnare la fiducia di molti ricercatori impegnati in campo biotecnologico, biomedico e diagnostico. Il contatto continuo con la ricerca promuove collaborazioni mirate allo sviluppo di prodotti industrializzabili, disponibili a tutti.
1 to 10 staff
Eaba - European Algae Biomass Association
The general objective of the European Algae Biomass Association (EABA) is to promote mutual interchange and cooperation in the field of biomass production and use, including biofuels uses and all other utilisations. It aims at creating, developing and maintaining solidarity and links between its Members and at defending their interests at European and international level. Its main target is to act as a catalyst for fostering synergies among scientists, industrialists and decision makers in order to promote the development of research, technology and industrial capacities in the field of Algae. In this perspective EABA intends to constitute a basis for- Establishing a permanent liaison with EU and EU Member States’ Institutions - Defining and expressing a common position on EU issues (legislation, product specifications, trade and sustainability standards, etc.), acting as a technology neutral platform - Representing the European biomass industry and scientific community at international level Spreading scientific information and knowledge about biomass and biofuels production - Making research and industry alive in public debate - Promoting investment and financial support in the field of Algae - Helping the structuring and planning of research and industrial development on Algae - Fostering scientific freedom as well as responsibility - Studying all economic and technical problems which may impact the sector in the European Union and related countries and studying all the direct and indirect environmental, social and economic effects of production and use - Breaking scientific boundaries on Algae - Promoting the exchange of scientific information and the publication of sound articles
11 to 50 staff
Xeptagen S.P.A
XEPTAGEN SpA is engaged in the discovery and validation of novel molecular markers in order to produce innovative diagnostic kits for cancer early detection, monitoring, and evaluation of response to therapy. By exploiting the natural immune response to early stage cancer and the proprietary platform technology Combinatorial Proteomic®, XEPTAGEN has discovered predictive, prognostic and early response tumor markers that lead to an earlier and much more accurate detection of developing carcinomas. Our mission includes creating innovative tools that improve the clinical management of cancer patients.
11 to 50 staff
Yeastime
Welcome to Yeastime's official linkedin page. Yeastime S.R.L is a biotech start up developing a deep tech hardware device to help breweries optimise their production process by reducing the active state of the fermentation by 30%, leading to efficiency in terms of production, energy consumption and environmental impact.
1 to 10 staff
Accurange S.R.L
La Accurange è stata costituita nell’anno 2013 con sede a Siena ed opera in accordo alla norma ISO 9001, dall’inizio della propria attività. Essa ha deciso di puntare su risorse tecniche giovani e fortemente motivate, infatti l’età media attuale dei tecnici di Accurange è di circa 30 anni. L’attività della società è sempre consistita, nell’erogazione di servizi di calibrazione e taratura pipette in accordo alla norma ISO 8655:2002.
1 to 10 staff
